Health Care/Hospital

Samsung Biologics reports third quarter 2024 financial results

* Recorded Q3'24 consolidated revenue of KRW 1.2 trillion * Recorded Q3'24 consolidated operating profit of KRW 338.6 billion * Continued business expansion through strong competitive edge in speed and execution INCHEON, South Korea, Oct. 23, 2024 /PRNewswire/ -- Samsung Biologics (KRX: 2079...

2024-10-23 14:55 1117

Halloween 2024: Wisesky Drives New Trend of Healthy Living with Early Bird Black Friday Deal on Its Advanced W-Cat Air Purifier Designed Specifically for Cats

LOS ANGELES, Oct. 23, 2024 /PRNewswire/ -- Wisesky , an innovative brand that focuses on air purification technology and is committed to solving the problems faced by pet-raising families, is ...

2024-10-23 14:53 844

TraceLink's New Singapore Office Fuels Expansion and Operational Excellence in APAC

Strengthening Regional Presence and Increasing Support for APAC Customers SINGAPORE, Oct. 23, 2024 /PRNewswire/ -- TraceLink, the largest end-to-end digital network platform for intelligent orchestration of the supply chain, has announced the opening of its new office inSingapore. This expansion ...

2024-10-23 10:00 1339

Australia's Healthcare Innovators in Stroke and Paediatric Care Honoured at 2024 Challenger Summit

Life sciences investor Proto Axiom awards $250,000 in prizes at inaugural Summit SYDNEY, Oct. 23, 2024 /PRNewswire/ -- The 2024 Challenger Summit concluded with two visionary researchers recognised for their groundbreaking contributions to treatment of stroke and paediatric skin care. The Summit...

2024-10-23 09:29 1322

AIMed 2024: A Pioneer in Healthcare Innovation to Join Key AI in Medicine Event

SAN ANTONIO, Oct. 23, 2024 /PRNewswire/ -- Frost & Sullivan proudly announce that Reenita Das, Partner and Senior Vice President of Healthcare & Life Sciences, will attend the highly anticipated AIMed 2024 Global Summit. The event, held fromNovember 17 - 19, 2024, 2024, will bring together health...

2024-10-23 00:03 1295

Harnessing Generative AI in Healthcare and Improving Cardiometabolic Health with Precision Medicine: Key Opportunities and Insights

HOUSTON, Oct. 22, 2024 /PRNewswire/ -- In today's rapidly evolving healthcare landscape, two powerful forces are reshaping how we diagnose, treat, and manage health conditions: Generative artificial intelligence (GenAI) and precision medicine for cardiometabolic health. GenAI promises to revoluti...

2024-10-22 22:51 1294

Nisun International Enters Strategic Partnership with Beijing Tong Ren Tang to Source Traditional Chinese Medicine Ingredients

Company Initiates Share Repurchases Under $15 Million Buyback Program SHANGHAI, Oct. 22, 2024 /PRNewswire/ -- Nisun International Enterprise Development Group Co., Ltd. ("Nisun International" or the "Company") (Nasdaq: NISN), a technology and industry driven integrated supply chain solutions pro...

2024-10-22 21:29 2304

Bloomage 'YunZhong (In Cloud) Public Welfare' Campaign: A 14-Year Journey of Cultural Preservation and Sustainability

PARSIPPANY, N.J., Oct. 22, 2024 /PRNewswire/ -- Bloomage, a global leader in the research, development, production, and sale of hyaluronic acid and other bioactive substances, continues to showcase its leadership in Environmental, Social, and Governance (ESG) initiatives. The company'sYunZhong (I...

2024-10-22 21:00 1411

Telix Spins Off Rhine Pharma™ to Expand Global Access to Radiopharmaceuticals

MELBOURNE, Australia, Oct. 22, 2024 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces the spin-off of Rhine Pharma[1], which has the mission of expanding global access to innovative radiopharmaceuticals for cancer imaging and treatment using two gen...

2024-10-22 18:57 1656

Minghui Pharmaceutical Inc. Announces Positive Topline Results from Phase Ib/II Clinical Trial of MHB018A, a Subcutaneous Single-Domain IGF-1R Antibody, in Patients with Active, Moderate-to-Severe Thyroid Eye Disease (TED)

SHANGHAI, Oct. 22, 2024 /PRNewswire/ -- Minghui Pharmaceutical, Inc., a late-stage biopharmaceutical company dedicated to developing transformative medicines in immunology and oncology, today announced positive topline results from its Phase Ib/II clinical trial of MHB018A in patients with active...

2024-10-22 18:00 4658

World Psoriasis Day 2024: Psoriatic Disease and Family--Standing Together in Support and Understanding

STOCKHOLM, Oct. 22, 2024 /PRNewswire/ -- Each year on October 29th, the global community unites on World Psoriasis Day to raise awareness and advocate for progress in the fight against psoriatic disease. This year, the focus is on the profound impact of psoriatic disease on families, highlighted ...

2024-10-22 16:00 2135

HELP Therapeutics announces FDA clearance of IND application for universal iPSC-derived HiCM-188 cell therapy for the treatment of end-stage heart failure

NANJING, China, Oct. 22, 2024 /PRNewswire/ -- HELP Therapeutics Co. Ltd, a clinical-stage cell therapy company,today announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for "Allogeneic Human iPSC-derived cardiomyocytes (HiCM-188) a...

2024-10-22 13:47 1007

South Korean Mental Tech Startup DoctorPresso Publishes Study to Detect Depression from User-Generated Diary test data in International Journal

SEOUL, South Korea, Oct. 21, 2024 /PRNewswire/ -- Doctorpresso's study to detect depression from user-generated diary text data was published in the September 2024 issue of the Journal of Medical Internet Research (JMIR) in recognition of its excellence. JMIR noted the "new approach of Doctorpress...

2024-10-22 09:08 1788

Everest Medicines Announces Positive Results of Complete Chinese Subpopulation Data from the NEFECON® Global Phase 3 NefIgArd Clinical Trial Published in "Kidney 360" Magazine

SHANGHAI, Oct. 22, 2024 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization of innovative therapeutics, today announced that the "Kidney 360" magazine has pu...

2024-10-22 07:40 1741

【C.S】Cordyceps Sunshine Biotech Uplists to OTCQB, Aims for a Potential Nasdaq Uplisting

TAIPEI, Oct. 22, 2024 /PRNewswire/ -- Cordyceps Sunshine Biotech Holdings Co., Ltd. 【C.S】Group, recognized for its expertise in cultivating the rare medicinal fungusTaiwanofungus, native to Taiwan, has reached a significant milestone by uplisting to the OTCQB market.

2024-10-22 06:00 1341

A Comprehensive Introduction of the oneClick+ antigen platform

SHANGHAI, Oct. 21, 2024 /PRNewswire/ -- Sanyou Bio provides oneClick+ antigen one-stop solution, from antigen analysis to personalized preparation, to help tumor immunotherapy research and development. oneClick+ antigen platform is designed to provide high-quality annotation-related protein seque...

2024-10-22 03:00 1250

Moleac Announces PT Ferron Par Pharmaceuticals as New Exclusive Partner in Indonesia

SINGAPORE, Oct. 21, 2024 /PRNewswire/ -- Moleac is excited to announce a significant milestone in the journey of NeuroAiD II MLC901 asPT Ferron Par Pharmaceuticalswill become our exclusive partner in Indonesia effective Jan 1st 2025. We are immensely grateful for the fruitful 12-year partnership...

2024-10-21 22:20 1762

Datasea Announces the Closing of a $4.0 Million Private Offering, Primarily Funded by the Company's CEO and Director

BEIJING, Oct. 21, 2024 /PRNewswire/ -- Datasea Inc. (NASDAQ: DTSS) ("Datasea" or the "Company"), aNevada-based digital technology company focused on innovative high-tech acoustics and 5G AI multimodal digital technology, today announced that, as ofOctober 15, 2024, the Company closed its Regulati...

2024-10-21 21:30 2340

Ping An Reports Steady Growth in Operating Profit, Robust Increases in Net Profit and Life & Health NBV in 9M 2024

HONG KONG and SHANGHAI, Oct. 21, 2024 /PRNewswire/ -- Ping An Insurance (Group) Company ofChina, Ltd. (hereafter "Ping An", or the "Group", HKEX: 2318 / 82318; SSE: 601318) today announced its results for the nine months endedSeptember 30, 2024.  In the first nine months of 2024, China's economy...

2024-10-21 20:17 2274

Origin Agritech Establishes Biotechnology Service Consortium to Accelerate Licensing and Commercialization of GMO and Gene Editing Technologies

BEIJING, Oct. 21, 2024 /PRNewswire/ -- Origin Agritech Ltd. (NASDAQ: SEED) (the "Company" or "Origin"), a leading Chinese agricultural technology company, is pleased to announce the establishment of the "Origin Marker Biological Breeding Service Consortium" in partnership with China Golden Marker...

2024-10-21 19:30 1257
1 ... 15161718192021 ... 847